138 related articles for article (PubMed ID: 35456876)
21. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
Lasfar A; Lewis-Antes A; Smirnov SV; Anantha S; Abushahba W; Tian B; Reuhl K; Dickensheets H; Sheikh F; Donnelly RP; Raveche E; Kotenko SV
Cancer Res; 2006 Apr; 66(8):4468-77. PubMed ID: 16618774
[TBL] [Abstract][Full Text] [Related]
22. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.
Stoltz M; Klingström J
J Virol; 2010 Sep; 84(18):9140-8. PubMed ID: 20592090
[TBL] [Abstract][Full Text] [Related]
23. Interferon Lambda: Modulating Immunity in Infectious Diseases.
Syedbasha M; Egli A
Front Immunol; 2017; 8():119. PubMed ID: 28293236
[TBL] [Abstract][Full Text] [Related]
24. Interferon-lambda: a new addition to an old family.
Donnelly RP; Kotenko SV
J Interferon Cytokine Res; 2010 Aug; 30(8):555-64. PubMed ID: 20712453
[TBL] [Abstract][Full Text] [Related]
25. Human interferon-lambda3 is a potent member of the type III interferon family.
Dellgren C; Gad HH; Hamming OJ; Melchjorsen J; Hartmann R
Genes Immun; 2009 Mar; 10(2):125-31. PubMed ID: 18987645
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of canine interferon-lambda.
Fan W; Xu L; Ren L; Qu H; Li J; Liang J; Liu W; Yang L; Luo T
J Interferon Cytokine Res; 2014 Nov; 34(11):848-57. PubMed ID: 24950142
[TBL] [Abstract][Full Text] [Related]
27. Interferon lambda inhibits dengue virus replication in epithelial cells.
Palma-Ocampo HK; Flores-Alonso JC; Vallejo-Ruiz V; Reyes-Leyva J; Flores-Mendoza L; Herrera-Camacho I; Rosas-Murrieta NH; Santos-López G
Virol J; 2015 Sep; 12():150. PubMed ID: 26411318
[TBL] [Abstract][Full Text] [Related]
28. Endogenously produced TNF-α contributes to the expression of CXCL10/IP-10 in IFN-λ3-activated plasmacytoid dendritic cells.
Finotti G; Tamassia N; Calzetti F; Fattovich G; Cassatella MA
J Leukoc Biol; 2016 Jan; 99(1):107-19. PubMed ID: 26382296
[TBL] [Abstract][Full Text] [Related]
29. Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
Murata K; Asano M; Matsumoto A; Sugiyama M; Nishida N; Tanaka E; Inoue T; Sakamoto M; Enomoto N; Shirasaki T; Honda M; Kaneko S; Gatanaga H; Oka S; Kawamura YI; Dohi T; Shuno Y; Yano H; Mizokami M
Gut; 2018 Feb; 67(2):362-371. PubMed ID: 27789659
[TBL] [Abstract][Full Text] [Related]
30. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function.
Broggi A; Tan Y; Granucci F; Zanoni I
Nat Immunol; 2017 Oct; 18(10):1084-1093. PubMed ID: 28846084
[TBL] [Abstract][Full Text] [Related]
31. Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects.
Li Q; Kawamura K; Okamoto S; Fujie H; Numasaki M; Namba M; Nagata M; Shimada H; Kobayashi H; Tagawa M
Br J Cancer; 2011 Oct; 105(9):1302-12. PubMed ID: 21952623
[TBL] [Abstract][Full Text] [Related]
32. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
33. Effects of lactoferrin on the production of interferon-λ by the human intestinal epithelial cell line HT-29.
Shin K; Oda H; Wakabayashi H; Yamauchi K; Abe F
Biochem Cell Biol; 2017 Feb; 95(1):53-56. PubMed ID: 28157388
[TBL] [Abstract][Full Text] [Related]
34. Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.
Dickensheets H; Sheikh F; Park O; Gao B; Donnelly RP
J Leukoc Biol; 2013 Mar; 93(3):377-85. PubMed ID: 23258595
[TBL] [Abstract][Full Text] [Related]
35. Interferons lambda, new cytokines with antiviral activity.
Lopušná K; Režuchová I; Betáková T; Skovranová L; Tomašková J; Lukáčiková L; Kabát P
Acta Virol; 2013; 57(2):171-9. PubMed ID: 23600875
[TBL] [Abstract][Full Text] [Related]
36. Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.
Kim DH; Park BJ; Ahn HS; Go HJ; Kim DY; Kim JH; Lee JB; Park SY; Song CS; Lee SW; Choi IS
Virus Res; 2021 Apr; 296():198342. PubMed ID: 33607185
[TBL] [Abstract][Full Text] [Related]
37. Alcohol attenuates anti-HCV function of IFN-λ1 through up-regulation of PLASy expression in human hepatic cells.
Ran M; Huang J; Liang H; Jiang J; Liang B; Ning C; Zang N; Liao W; Liu H; Qin F; Yang Q; Ho W; Ye L; Chen H
J Med Virol; 2018 Jun; 90(6):1112-1120. PubMed ID: 29446489
[TBL] [Abstract][Full Text] [Related]
38. Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents.
Li Q; Kawamura K; Ma G; Iwata F; Numasaki M; Suzuki N; Shimada H; Tagawa M
Eur J Cancer; 2010 Jan; 46(1):180-90. PubMed ID: 19879751
[TBL] [Abstract][Full Text] [Related]
39. Expression of
Baldridge MT; Lee S; Brown JJ; McAllister N; Urbanek K; Dermody TS; Nice TJ; Virgin HW
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077655
[TBL] [Abstract][Full Text] [Related]
40. Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling.
Zhang Q; Ke H; Blikslager A; Fujita T; Yoo D
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
